Tectonic Therapeutic | Frais De Vente Et D'Administration



Selling And Administration Expenses Changement Date
Adcock Ingram Holdings ZAR 1.05B 50.17M 2024-12
Alnylam Pharmaceuticals USD 323.31M 83.36M 2025-06
Celltrion KRW 276.8B 58.09B 2025-03
Cspc Pharmaceutical CNY 1.89B 347.81M 2025-03
Dianthus Therapeutics USD 6.83M 287K 2024-12
Divis Laboratories Ltd 3.4B 10M 2025-06
Gilead Sciences USD 1.36B 100M 2025-06
Ionis Pharmaceuticals USD 90.6M 14.6M 2025-06
Kangmei Pharma CNY 209.56M 118.34M 2025-03
Knight Therapeutics CAD 25.48M 119K 2024-09
Laboratorios Farma EUR 32.57M 26.69M 2024-06
MacroGenics USD 27.81M 13.71M 2024-12
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 12.94M 5.87M 2024-12
Neuren Pharmaceuticals AUD 2.33M 47K 2024-12
Organigram Holdings CAD 17.19M 2.88M 2024-12
Pfizer USD 3.42B 406M 2025-06
Pharma Mar EUR 14.68M 1M 2025-06
Qiagen NV USD 148.74M 10.8M 2025-06
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.63B 408M 2025-06
Sarepta Therapeutics USD 69.89M 63.74M 2025-06
Sartorius EUR 225.2M 6.7M 2025-06
Sino Biopharmaceutical CNY 5.31B 1.54B 2024-12
Takeda JPY 255.89B 39.98B 2025-06
Tilray USD 72.38M 4.99M 2024-11
Zz Pientze Pharmaceu 171.29M 130.03M 2025-03


Tectonic Therapeutic Frais De Vente Et D'Administration - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.